Leonteq Securities’s Novavax NVAX Stock Holding History
Bought
Maintained
Sold
Other funds holding NVAX
Leonteq Securities's NVAX Position: Q3 2026 in Review
Leonteq Securities increased its Novavax (NVAX) stake by 4.8% in Q3 2026, buying an estimated $7.03K and bringing the position to 17,248 shares worth $186K. The position accounts for 0.01% of the portfolio, ranked #526.
Leonteq Securities first reported a position in NVAX in Q4 2020 and has held it in 24 quarters since. The position peaked at $11.9M in Q4 2021. 254 funds tracked by Wall St. Rank hold NVAX as of Q3 2026.
- Leonteq Securities held 17,248 shares of Novavax worth $186K as of Q3 2026.
- Leonteq Securities bought 784 Novavax shares in Q3 2026, an estimated $7.03K.
- Novavax made up 0.01% of Leonteq Securities's portfolio in Q3 2026, its #526 holding.
- Leonteq Securities first reported a position in Novavax in Q4 2020 and has held it in 24 quarters since.
- Leonteq Securities's Novavax position peaked at $11.9M in Q4 2021.
- 254 funds tracked by Wall St. Rank held Novavax as of Q3 2026.
Based on Leonteq Securities's 13F filing for Q3 2026, filed 29 Oct 2026.